Form 4 for NVCR NovoCure Ltd
Accepted 2021-09-07 00:00:00 ET · period of report 2021-09-02 · accession 0001645113-21-000106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-07 | 2021-09-02+ | NVCR | Shah Pritesh | Chief Commercial Off | S - Sale | $138.57 | -657 | 73.7K | -0.9% | -$91.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-09-02 | S | D | 156 | $138.23 | 74,013 | D | — | — | (F1) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| 2 | Common | Ordinary Shares | 2021-09-03 | S | D | 30 | $140.18 | 73,512 | D | — | — | (F4) Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah. |
| 3 | Common | Ordinary Shares | 2021-09-03 | S | D | 150 | $139.24 | 73,542 | D | — | — | (F3) On September 3, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 150 shares in multiple trades at prices ranging from $138.81 to $139.78. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Ordinary Shares | 2021-09-03 | S | D | 321 | $138.27 | 73,692 | D | — | — | (F2) On September 3, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 321 shares in multiple trades at prices ranging from $137.75 to $138.56. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. |